Musculoskeletal oncology and thermal ablation: the current and emerging role of interventional radiology.

Ablation techniques Bone metastases Bone neoplasms Cementoplasty Cryoablation Desmoid tumour High-intensity focused ultrasound MRgFUS Osteoblastoma Osteoid osteoma Radiofrequency ablation Radiology, interventional Soft tissue neoplasms

Journal

Skeletal radiology
ISSN: 1432-2161
Titre abrégé: Skeletal Radiol
Pays: Germany
ID NLM: 7701953

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 28 02 2022
accepted: 17 10 2022
revised: 05 10 2022
pubmed: 9 11 2022
medline: 20 1 2023
entrez: 8 11 2022
Statut: ppublish

Résumé

The role of interventional radiology (IR) is expanding. With new techniques being developed and tested, this radiology subspecialty is taking a step forward in different clinical scenarios, especially in oncology. Musculoskeletal tumoral diseases would definitely benefit from a low-invasive approach that could reduce mortality and morbidity in particular. Thermal ablation through IR has already become important in the palliation and consolidation of bone metastases, oligometastatic disease, local recurrences, and treating specific benign tumors, with a more tailored approach, considering the characteristics of every patient. As image-guided ablation techniques lower their invasiveness and increase their efficacy while the collateral effects and complications decrease, they become more relevant and need to be considered in patient care pathways and clinical management, to improve outcomes. We present a literature review of the different percutaneous and non-invasive image-guided thermal ablation methods that are currently available and that could in the future become relevant to manage musculoskeletal oncologic diseases.

Identifiants

pubmed: 36346453
doi: 10.1007/s00256-022-04213-3
pii: 10.1007/s00256-022-04213-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

447-459

Informations de copyright

© 2022. The Author(s), under exclusive licence to International Skeletal Society (ISS).

Références

Siegel RL, Miller KD, Jemal A. Cancer statistics. CA A Cancer J Clin. 2017;67:7–30.
doi: 10.3322/caac.21387
Jiang W, Rixiati Y, Zhao B, Li Y, Tang C, Liu J. Incidence, prevalence, and outcomes of systemic malignancy with bone metastases. J Orthop Surg (Hong Kong). 2020;28:230949902091598.
doi: 10.1177/2309499020915989
Hagiwara M, Delea TE, Chung K. Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases. J Med Econ. 2014;17:223–30.
doi: 10.3111/13696998.2014.890937
Hagiwara M, Delea TE, Saville MW, Chung K. Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. 2013;16:23–7.
doi: 10.1038/pcan.2012.42
Durán I, Garzón C, Sánchez A, García-Carbonero I, Pérez-Gracia JL, Seguí-Palmer MÁ, et al. Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours. Clin Transl Oncol. 2014;16:322–9.
doi: 10.1007/s12094-013-1077-2
Cazzato RL, Arrigoni F, Boatta E, Bruno F, Chiang JB, Garnon J, et al. Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR). Radiol med. 2019;124:34–49.
doi: 10.1007/s11547-018-0938-8
Cazzato RL, Palussière J, Auloge P, Rousseau C, Koch G, Dalili D, et al. Complications following percutaneous image-guided radiofrequency ablation of bone tumors: a 10-year dual-center experience. Radiology. 2020;296:227–35.
doi: 10.1148/radiol.2020191905
Levy J, Hopkins T, Morris J, Tran ND, David E, Massari F, et al. radiofrequency ablation for the palliative treatment of bone metastases: outcomes from the Multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 Patients. J Vasc Interv Radiol. 2020;31:1745–52.
doi: 10.1016/j.jvir.2020.07.014
Dupuy DE, Liu D, Hartfeil D, Hanna L, Blume JD, Ahrar K, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010;116:989–97.
doi: 10.1002/cncr.24837
Pusceddu C, Sotgia B, Fele RM, Melis L. Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol. 2013;24:229–33.
doi: 10.1016/j.jvir.2012.10.009
Arrigoni F, Bruno F, Zugaro L, Natella R, Cappabianca S, Russo U, et al. Developments in the management of bone metastases with interventional radiology. Acta Biomed. 2018;89:166–74.
Hayek G, Kastler B. Interventional radiology for treatment of bone metastases. Cancer Radiother. 2020;24:374–8.
doi: 10.1016/j.canrad.2020.04.006
Chiras J, Shotar E, Cormier E, Clarençon F. Interventional radiology in bone metastases. Eur J Cancer Care. 2017;26:e12741.
doi: 10.1111/ecc.12741
Callstrom MR, Dupuy DE, Solomon SB, Beres RA, Littrup PJ, Davis KW, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer. 2013;119:1033–41.
doi: 10.1002/cncr.27793
Auloge P, Cazzato RL, Rousseau C, Caudrelier J, Koch G, Rao P, et al. Complications of Percutaneous Bone Tumor Cryoablation: A 10-year Experience. Radiology. 2019;291:521–8.
doi: 10.1148/radiol.2019181262
Jennings JW, Prologo JD, Garnon J, Gangi A, Buy X, Palussière J, et al. Cryoablation for palliation of painful bone metastases: The MOTION Multicenter Study. Radiol: Imaging Cancer. 2021;3:e200101.
Moses ZB, Lee TC, Huang KT, Guenette JP, Chi JH. MRI-guided cryoablation for metastatic spine disease: intermediate-term clinical outcomes in 14 consecutive patients. J Neurosurg Spine. 2020;17:1–6. https://doi.org/10.3171/2019.11.SPINE19808 .
doi: 10.3171/2019.11.SPINE19808
Cazzato RL, Garnon J, Koch G, Dalili D, Rao PP, Weiss J, et al. Musculoskeletal interventional oncology: current and future practices. Br J Radiol. 2020;93:20200465.
doi: 10.1259/bjr.20200465
Deschamps F, Farouil G, Ternes N, Gaudin A, Hakime A, Tselikas L, et al. Thermal ablation techniques: a curative treatment of bone metastases in selected patients? Eur Radiol. 2014;24:1971–80.
doi: 10.1007/s00330-014-3202-1
Aubry S, Dubut J, Nueffer J-P, Chaigneau L, Vidal C, Kastler B. Prospective 1-year follow-up pilot study of CT-guided microwave ablation in the treatment of bone and soft-tissue malignant tumours. Eur Radiol. 2017;27:1477–85.
doi: 10.1007/s00330-016-4528-7
Tomasian A, Wallace A, Northrup B, Hillen TJ, Jennings JW. Spine Cryoablation: Pain Palliation and Local Tumor Control for Vertebral Metastases. AJNR Am J Neuroradiol. 2016;37:189–95.
doi: 10.3174/ajnr.A4521
Ma Y, Wallace AN, Waqar SN, Morgensztern D, Madaelil TP, Tomasian A, et al. Percutaneous Image-Guided Ablation in the Treatment of Osseous Metastases from Non-small Cell Lung Cancer. Cardiovasc Intervent Radiol. 2018;41:726–33.
Gardner CS, Ensor JE, Ahrar K, Huang SY, Sabir SH, Tannir NM, et al. Cryoablation of bone metastases from renal cell carcinoma for local tumor control. J Bone Joint Surg Am. 2017;99:1916–26.
doi: 10.2106/JBJS.16.01182
Erie AJ, Morris JM, Welch BT, Kurup AN, Weisbrod AJ, Atwell TD, et al. Retrospective review of percutaneous image-guided ablation of oligometastatic prostate cancer: a single-institution experience. J Vasc Interv Radiol. 2017;28:987–92.
doi: 10.1016/j.jvir.2017.03.012
Wallace AN, Tomasian A, Vaswani D, Vyhmeister R, Chang RO, Jennings JW. radiographic local control of spinal metastases with percutaneous radiofrequency ablation and vertebral augmentation. AJNR Am J Neuroradiol. 2016;37:759–65.
doi: 10.3174/ajnr.A4595
Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Weisbrod AJ, et al. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol. 2014;192:357–63.
doi: 10.1016/j.juro.2014.03.006
McMenomy BP, Kurup AN, Johnson GB, Carter RE, McWilliams RR, Markovic SN, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013;24:207–13.
doi: 10.1016/j.jvir.2012.10.019
Bang HJ, Littrup PJ, Currier BP, Goodrich DJ, Aoun HD, Klein LC, et al. Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations. J Vasc Interv Radiol. 2012;23:761–9.
doi: 10.1016/j.jvir.2012.02.013
Vaswani D, Wallace AN, Eiswirth PS, Madaelil TP, Chang RO, Tomasian A, et al. Radiographic local tumor control and pain palliation of sarcoma metastases within the musculoskeletal system with percutaneous thermal ablation. Cardiovasc Intervent Radiol. 2018;41:1223–32.
doi: 10.1007/s00270-018-1932-1
Moynagh MR, Kurup AN, Callstrom MR. Thermal ablation of bone metastases. Semin Intervent Radiol. 2018;35:299–308.
doi: 10.1055/s-0038-1673422
Scipione R, Anzidei M, Bazzocchi A, Gagliardo C, Catalano C, Napoli A. HIFU for bone metastases and other musculoskeletal applications. Semin intervent Radiol. 2018;35:261–7.
doi: 10.1055/s-0038-1673363
Baal JD, Chen WC, Baal U, Wagle S, Baal JH, Link TM, et al. Efficacy and safety of magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: a systematic review and meta-analysis. Skeletal Radiol. 2021;50:2459–69.
doi: 10.1007/s00256-021-03822-8
Winkelmann MT, Clasen S, Pereira PL, Hoffmann R. Local treatment of oligometastatic disease: current role. BJR. 2019;92:20180835.
doi: 10.1259/bjr.20180835
Grünwald V, Eberhardt B, Bex A, Flörcken A, Gauler T, Derlin T, et al. An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma. Nat Rev Urol. 2018;15:511–21.
doi: 10.1038/s41585-018-0034-9
Chotel F, Franck F, Solla F, Dijoud F, Kohler R, Berard J, et al. Osteoid osteoma transformation into osteoblastoma: Fact or fiction? Orthop Traumatol Surg Res. 2012;98:S98-104.
doi: 10.1016/j.otsr.2012.03.017
Geiger D, Napoli A, Conchiglia A, Gregori LM, Arrigoni F, Bazzocchi A, et al. MR-guided Focused Ultrasound (MRgFUS) Ablation for the treatment of nonspinal osteoid osteoma: a prospective multicenter evaluation. J Bone Joint Surg. 2014;96:743–51.
doi: 10.2106/JBJS.M.00903
Arrigoni F, Napoli A, Bazzocchi A, Zugaro L, Scipione R, Bruno F, et al. Magnetic-resonance-guided focused ultrasound treatment of non-spinal osteoid osteoma in children: multicentre experience. Pediatr Radiol. 2019;49:1209–16.
doi: 10.1007/s00247-019-04426-0
Arrigoni F, Spiliopoulos S, de Cataldo C, Reppas L, Palumbo P, Mazioti A, et al. A Bicentric propensity score matched study comparing percutaneous computed tomography–guided radiofrequency ablation to magnetic resonance–guided focused ultrasound for the treatment of osteoid osteoma. J Vasc Interv Radiol. 2021;32:1044–51.
doi: 10.1016/j.jvir.2021.03.528
Albisinni U, Facchini G, Spinnato P, Gasbarrini A, Bazzocchi A. Spinal osteoid osteoma: efficacy and safety of radiofrequency ablation. Skeletal Radiol. 2017;46(8):1087–94.
doi: 10.1007/s00256-017-2662-1
Beyer T, van Rijswijk CSP, Villagra ́n JM, et al. European multicentre study on technical success and long-term clinical outcome of radiofrequency ablation for the treatment of spinal osteoid osteomas and osteoblastomas. Neuroradiol. 2019;61(8):935–42.
doi: 10.1007/s00234-019-02226-9
Wang B, Han SB, Jiang L, et al. Percutaneous radiofrequency ablation for spinal osteoid osteoma and osteoblastoma. Eur Spine J. 2017;26(7):1884–92.
doi: 10.1007/s00586-017-5080-0
Faddoul J, Faddoul Y, Kobaiter-Maarrawi S, et al. Radiofrequency ablation of spinal osteoid osteoma: a prospective study. J Neurosurg Spine. 2017;26(3):313–8.
doi: 10.3171/2016.8.SPINE16462
Klass D, Marshall T, Toms A. CT-guided radiofrequency ablation of spinal osteoid osteomas with concomitant perineural and epidural irrigation for neuroprotection. Eur Radiol. 2009;19(9):2238–43.
doi: 10.1007/s00330-009-1404-8
Tsoumakidou G, Thénint M-A, Garnon J, Buy X, Steib J-P, Gangi A. Percutaneous image-guided laser photocoagulation of spinal osteoid osteoma: a single-institution Series. Radiol. 2016;278:936–43.
doi: 10.1148/radiol.2015150491
Santiago E, Pauly V, Brun G, Guenoun D, Champsaur P, Le Corroller T. Percutaneous cryoablation for the treatment of osteoid osteoma in the adult population. Eur Radiol. 2018;28:2336–44.
doi: 10.1007/s00330-017-5164-6
Koch G, Cazzato R, Gilkison A, Caudrelier J, Garnon J, Gangi A. Percutaneous treatments of benign bone tumors. Semin intervent Radiol. 2018;35:324–32.
doi: 10.1055/s-0038-1673640
Arrigoni F, Bruno F, Palumbo P, Zugaro L, Zoccali C, Barile A, et al. Magnetic resonance-guided focused ultrasound surgery treatment of non-spinal intra-articular osteoblastoma: feasibility, safety, and outcomes in a single-center retrospective analysis. Int J Hyperth. 2019;36:767–74.
doi: 10.1080/02656736.2019.1639833
Nuyttens JJ, Rust PF, Thomas CR, Turrisi AT. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer. 2000;88:1517–23.
doi: 10.1002/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.0.CO;2-9
Kasper B, Baumgarten C, Garcia J, Bonvalot S, Haas R, Haller F, et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017;28:2399–408.
doi: 10.1093/annonc/mdx323
Redifer Tremblay K, Lea WB, Neilson JC, King DM, Tutton SM. Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol. 2019;120:366–75.
doi: 10.1002/jso.25597
Schmitz JJ, Schmit GD, Atwell TD, Callstrom MR, Kurup AN, Weisbrod AJ, Morris JM. Percutaneous cryoablation of extraabdominal desmoid tumors: a 10-year experience. AJR Am J Roentgenol. 2016;207(1):190–5. https://doi.org/10.2214/AJR.15.14391 .
doi: 10.2214/AJR.15.14391
Ghanouni P, Dobrotwir A, Bazzocchi A, Bucknor M, Bitton R, Rosenberg J, et al. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study. Eur Radiol. 2017;27:732–40.
doi: 10.1007/s00330-016-4376-5
Galibert P, Deramond H, Rosat P. Le Gars D [Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty]. Neurochirurgie. 1987;33:166–8.
Moulin B, Tselikas L, De Baere T, Varin F, Abed A, Debays L, et al. CT guidance assisted by electromagnetic navigation system for percutaneous fixation by internal cemented screws (FICS). Eur Radiol. 2020;30:943–9.
doi: 10.1007/s00330-019-06408-0
Kelekis A, Filippiadis D, Anselmetti G, Brountzos E, Mavrogenis A, Papagelopoulos P, et al. Percutaneous augmented peripheral osteoplasty in long bones of oncologic patients for pain reduction and prevention of impeding pathologic fracture: the Rebar concept. Cardiovasc Intervent Radiol. 2016;39:90–6.
doi: 10.1007/s00270-015-1138-8
Wallace AN, Robinson CG, Meyer J, Tran ND, Gangi A, Callstrom MR, et al. The metastatic spine disease multidisciplinary working group algorithms. Oncologist. 2015;20:1205–15.
doi: 10.1634/theoncologist.2015-0085
Filippiadis D, Kelekis A. Percutaneous bipolar radiofrequency ablation for spine metastatic lesions. Eur J Orthop Surg Traumatol. 2021;31:1603–10.
doi: 10.1007/s00590-021-02947-9
Muto M. Spine intervention. Eur J Radiol. 2015;84:745.
doi: 10.1016/j.ejrad.2014.07.001
Metzner J, Posner KL, Domino KB. The risk and safety of anesthesia at remote locations: the US closed claims analysis. Curr Opin Anaesthesiol. 2009;22:502–8.
doi: 10.1097/ACO.0b013e32832dba50
Kim H, Lane J, Schlichter R, Stecker MS, Taus R. Use of anesthesiology services in radiology. Anesthesiol Clin. 2017;35(4):601–10. https://doi.org/10.1016/j.anclin.2017.07.005 .
doi: 10.1016/j.anclin.2017.07.005
Amin A, Lane J, Cutter T. An anesthesiologist’s view of tumor ablation in the radiology suite. Anesthesiol Clin. 2017;35(4):611–5. https://doi.org/10.1016/j.anclin.2017.07.006 .
doi: 10.1016/j.anclin.2017.07.006
Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR prac- tices: 2007. AJR Am J Roentgenol. 2007;188:1447–74.
doi: 10.2214/AJR.06.1616
American College of Radiology (ACR). ACR-SIR practice parameter for sedation/ analgesia, resolution 23, 2015. Available at: https://www.acr.org/w/media/ F194CBB800AB43048B997A75938AB482.pdf. Accessed March 11, 2017.

Auteurs

Alberto Bazzocchi (A)

Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Via G. C. Pupilli 1, 40136, Bologna, Italy. abazzo@inwind.it.

Maria Pilar Aparisi Gómez (MP)

Department of Radiology, Auckland City Hospital, Auckland, New Zealand.
Department of Radiology, IMSKE, Valencia, Spain.

Makoto Taninokuchi Tomassoni (M)

Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Via G. C. Pupilli 1, 40136, Bologna, Italy.

Alessandro Napoli (A)

Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

Dimitrios Filippiadis (D)

2nd Radiology Department, Medical School, University General Hospital "ATTIKON", National and Kapodistrian University of Athens, Athens, Greece.

Giuseppe Guglielmi (G)

Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH